Just when it had looked as if control of Australia’s largest cotton processor, Namoi Cotton would fall to one Singapore predator, another Singapore company which had been the underbidder has stepped back into the ring. Olam Agri Holdings announced today that it would increase its offer to buy the company to 66 cents cash, trumping…
Mesoblast secures FDA approval for heart disease treatment Biotechnology company Mesoblast has secured US Food and Drug Administration (FDA) approval for its Revascor heart disease treatment. The FDA issued a rare pediatric disease (RPD) designation for Revascor following submission of results from a trial in 19 children with hypoplastic left heart syndrome (HLHS). Revascor is…
By Peter Roberts Another day another takeover of an Australian manufacturer, this time of ginning company Namoi Cotton. The directors of the company, which operates 10 cotton gins on the east coast and in Northern Western Australia, have said they intend to recommended shareholders accept a takeover offer from Louis Dreyfus Company Asia Pte Ltd…
